BDNF Serum Levels are Associated With White Matter Microstructure in Schizophrenia - A Pilot Study.
Ontology highlight
ABSTRACT: Brain derived neurotrophic factor (BDNF) has been implicated in the pathophysiology of schizophrenia. As BDNF regulates axonal and dendritic growth, altered BDNF levels in schizophrenia patients might underlie changes in structural connectivity that have been identified by magnetic resonance imaging (MRI). We investigated a possible correlation between BDNF serum levels, fiber tract architecture, and regional grey matter volumes in 19 schizophrenia patients and a gender- and age-matched control group. Two patients had to be excluded due to abnormalities in their MRI scans. Serum samples were obtained to determine BDNF levels, and T1- as well as diffusion-weighted sequences were acquired. We, then, investigated correlations between BDNF serum levels with neuroimaging parameters, using Voxel
SUBMITTER: Hammans C
PROVIDER: S-EPMC7046752 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA